FDA Sets Fees for Import and Facility Reinspections for FY24; Invoices Remain on Hold
FDA set potential FY 2024 fees for import reinspections, domestic and foreign facility reinspections, and recall activities the agency performs if a firm fails to comply with a mandatory recall order, though it still isn't invoicing for services associated with the fees, it said in a notice. The agency set FY24 fees of $291 per hour for domestic services involving travel and $312 hourly if foreign travel is required.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
The fees are effective Oct. 1, the start of FY24. FDA again said it will not send invoices for recall activity and foreign facility reinspection fees until it publishes a guidance to outline the process through which small businesses may request a fee reduction, although fees will be assessed at the fee level in effect at the time of the activity (unless fees are reduced).
Fees for importer reinspection also remain on hold until "various issues" are resolved and the agency notifies the public (see 11100412), but these fee rates will be used to determine any importer reinspection fees that may be assessed in FY24. FDA said it still intends to issue a guidance document on fees the agency may assess and collect from importers to cover reinspection-related costs.